Event: The investment journey for advanced therapies

Join speakers from the investor community and industry to learn more about the investment journey for an advanced therapies company on 14 May, plus meet the RegMedNet team!

Go to the profile of Freya Leask
Apr 12, 2019
0
0

The second Advanced Therapies Network event on 14 May 2019 will bring together speakers from a range of organisations who have invested in advanced therapies companies such as Orchard Therapeutics and Autolus. It will also present the investment experience from the company perspective with insight from two companies working in advanced therapies. 

Companies working in this sector require a unique type of investor who believes in the huge potential of advanced therapies and who is prepared to work closely with the company to help them reach this potential.

The event will be held at 5.30 pm on 14 May 2019 at the Silicon Valley Bank, Moorgate, London.

What is the recipe for an advanced therapies unicorn?

A unicorn is a privately held startup company valued at over US$1 billion which is highly desirable but very rare; even rarer in the advanced therapies sector that is unique in the challenges it faces.

A panel of investors will discuss their own ‘recipes for an advanced therapies unicorn’, in terms of what they look for in a company and how they work with that company to try to make sure it reaches its full potential. The speakers on the panel are:

  • Nihal Sinha, Principal at F-Prime Capital
  • Simon Goldman, Investment Director at UCL Technology fund
  • Christine Martin, Investment Manager at Cambridge Enterprise
  • Kevin Pojasek, Venture Partner at SV Health Investors
  • Edward Hodgkin, Partner of Syncona Investment Management Ltd. 

Company Perspective

The event will also include an industry perspective with speakers from two advanced therapies companies:

  • Alex Blyth, CEO at LIfT Biosciences
  • Chris Williams, VP Business Development at Autolus

The speakers will talk about the investment challenges the companies have faced, how they have worked with investors and what they think are the essential ingredients for a unicorn in the advanced therapies sector.

Advanced Therapies Network

This event is the second of four events held this year which are open to the network’s members.

Signing up to become a member of the Advanced Therapies Network is free to those from academia and industry working in R&D in advanced therapies. Once signed up you can register for the event. If you are already a member you can sign in here.

RegMedNet

We’re excited to be supporting the Advanced Therapies Network and will be in attendance on 14 May! We will be filming some speakers as well as talking to attendees about the network and our partner journal, Regenerative Medicine.

Go to the profile of Freya Leask

Freya Leask

Publisher, Future Science Group

I am the Publisher of RegMedNet, 3DMedNet, RxNet and The Evidence Base, here to help users make the most of the websites and build our expert communities. I am passionate about digital and STM publishing, social media and story-telling. Please get in touch if you have any queries or comments!

No comments yet.